Drugs that contain Emedastine Difumarate
1. Emadine patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5441958 | NOVARTIS | Ophthalmic compositions comprising emedastine and methods for their use |
Dec, 2013
(10 years ago) | |
Market Authorisation Date: 29 December, 1997
Treatment: Treatment of allergic conjunctivitis
Dosage: SOLUTION/DROPS;OPHTHALMIC
More Information on Dosage
EMADINE family patents
